DIN 02525755 — OXLUMO 94.5 MG
OXLUMO is a solution of Lumasiran marketed by ALNYLAM NETHERLANDS B.V.. The full Lumasiran monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02525755
- Brand name
- OXLUMO
- Active ingredient
- Lumasiran
- Strength
- 94.5 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ALNYLAM NETHERLANDS B.V.
- Health Canada status
- MARKETED
- Drug class
- Hydroxyacid oxidase 1 (HAO1)-directed small interfering RNA (siRNA)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.